As a market, bionanotechnology is projected to grow world-wide by a rate of 28%. No further explanation is needed why the field is increasingly considered “the future of everything,” even if its potential for raising concerns is seldom overlooked and no FDA regulations exist to date.
As one can always safely assume with interdisciplinary areas, the father of all things is a dispute over terminology – in this case, the distinction, if any, between nanobiotechnology and bionanotechnology. Although enough ink is being spilled on that, it hardly matters: if nanobiotechnology, as a Lilliput version of biotechnology, takes concepts and fundamentals directly from nanotechnology to biotechnological use, bionanotechnology derives its concepts from mechanics, electricity, electronics, optics, and biology, and relates structural and mechanistic analysis of molecular-level biological processes into specific synthetic applications of nanotechnology. Not a distinction without a difference, but it matters little due to one principal characteristic of all nanotechnology: at the molecular and submolecular scale, biochemistry, biophysics, biology, and all other forms of human inquiry converge. Thus, multidisciplinarity is inherent.